Comparative efficacy and safety of IL-23 p19 monoclonal antibodies for plaque psoriasis: a bayesian network meta-analysis of randomized controlled trials
ObjectiveTo compare the efficacy and safety of IL-23 p19 monoclonal antibodies for moderate-to-severe plaque psoriasis.MethodsPubMed, Embase, Web of Science, and the Cochrane Library were searched from inception to 21 February 2026. We included randomi…